In a surprising turn of events, the U. S. government has reached an agreement with nine major pharmaceutical companies. The most talked-about part of this deal is Bristol Myers Squibb's decision to provide its popular blood thinner, Eliquis, at no cost to Medicaid recipients starting next year. Thi
Two big names in the medical world are teaming up to fight cancer. Bristol-Myers Squibb and BioNTech have struck a deal worth up to 11. 1 billion dollars. This is a huge amount of money. The deal is all about a new type of cancer treatment. This treatment uses the body's own immune system to fight
As the world continues to grapple with the complexities of cancer treatment, a new wave of innovation is emerging in the form of radiopharmaceuticals. These groundbreaking medications have the potential to revolutionize the way we approach cancer care, offering a targeted and minimally invasive appr
